Blessing Cancer Center

Quincy, Illinois 62301

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Small Cell Lung Cancer

Studies at this site

• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling
• Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy — Completed
• Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. — Completed